Since we could not observe the induction of apoptosis via clustering of BCR molecules in first initial experiments, we developed an alternative approach by generating vNAR antibody-drug conjugates that induced specific killing in lymphoma cells at low nanomolar concentrations. The gene discussed is BCR; the disease is lymphoma.